Media
Media
Our latest announcements
Hansa Biopharma participating at Leerink Global Healthcare Conference
06/03/2026
PDUFA Action Date for Hansa Biopharma’s Imlifidase BLA Set for December 19, 2026
Regulatory press release
04/03/2026
Hansa Biopharma presenting at TD Cowen’s 46th Annual Health Care Conference
23/02/2026
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase accepted by the FDA
Regulatory press release
18/02/2026
Media articles
Insights
The Power of Hope: Redefining Treatment Decisions for Highly Sensitized Kidney Patients
07/08/2025
Collaboration across the continuum of care to improve equity for highly sensitized people in kidney transplantation
17/07/2024
A concerted collaboration to advance treatment options for people living with rare diseases
26/06/2024
Fueling the future: the role of biotech in advancing innovative science and delivering new medicines
02/05/2024
Patients' perspective
Life on tour with chronic kidney disease
“I had always played the guitar and wrote songs but never really did anything with it. Nothing was going to hold me back now! No more excuses… there wasn’t time!”
Patients' perspective
Suspended time: a journey from diagnosis to transplant
"Dialysis may sound simple, but it isn’t, and over the course of his treatment Ron underwent several different kinds, all of which made him feel awful."
